Sanjun Cai - Search Results

Year	Number of Results
2003	2
2004	14
2006	2
2007	5
2008	6
2009	6
2010	18
2011	12
2012	6
2013	15
2014	33
2015	22
2016	21
2017	25
2018	31
2019	30
2020	32
2021	20
2022	17
2023	10
2024	3

1

Clinical and molecular heterogeneity associated with tumor sidedness in colorectal liver metastasis: a multicenter propensity cohort study.

Wu Y, Zhou J, Wang H, Fang G, Zhu W, Cai S, Wang L. Wu Y, et al. Among authors: cai s. Hepatobiliary Surg Nutr. 2024 Apr 3;13(2):214-228. doi: 10.21037/hbsn-22-285. Epub 2023 Mar 22. Hepatobiliary Surg Nutr. 2024. PMID: 38617480 Free PMC article.

2

Personalized circulating tumor DNA monitoring improves recurrence surveillance and management after curative resection of colorectal liver metastases: a prospective cohort study.

Li Y, Xu J, Hu X, Chen Y, Liu F, Chen Y, Ma X, Dong Q, Sun L, Mo S, Zhang L, He X, Tong S, Wu H, Li W, Cai S, Zhu S, Pan Q, Peng J. Li Y, et al. Among authors: cai s. Int J Surg. 2024 May 1;110(5):2776-2787. doi: 10.1097/JS9.0000000000001236. Int J Surg. 2024. PMID: 38445460 Free PMC article.

3

Study protocol of short-course radiotherapy combined with CAPOX and PD-1 inhibitor for locally advanced colon cancer: a randomised, prospective, multicentre, phase II trial (TORCH-C).

Zhang H, Li Y, Xia F, Sun Y, Shen L, Wan J, Chen Y, Wang Y, Zhou M, Wu R, Zhou S, Wang Y, Liu F, Cai S, Zhang Z. Zhang H, et al. Among authors: cai s. BMJ Open. 2024 Feb 2;14(2):e079442. doi: 10.1136/bmjopen-2023-079442. BMJ Open. 2024. PMID: 38309748 Free article.

4

Short-course radiotherapy combined with chemotherapy and PD-1 inhibitor in low-lying early rectal cancer: study protocol for a single-arm, multicentre, prospective, phase II trial (TORCH-E).

Chen Y, Wang Y, Zhang H, Wan J, Shen L, Wang Y, Zhou M, Wu R, Yang W, Zhou S, Cai S, Li X, Zhang Z, Xia F. Chen Y, et al. Among authors: cai s. BMJ Open. 2023 Oct 6;13(10):e076048. doi: 10.1136/bmjopen-2023-076048. BMJ Open. 2023. PMID: 37802608 Free PMC article.

5

Definitive carbon ion re-irradiation with pencil beam scanning in the treatment of unresectable locally recurrent rectal cancer.

Cai X, Li P, Zhao J, Wang W, Cheng J, Zhang G, Cai S, Zhang Z, Jiang G, Zhang Q, Wang Z. Cai X, et al. Among authors: cai s. J Radiat Res. 2023 Nov 21;64(6):933-939. doi: 10.1093/jrr/rrad068. J Radiat Res. 2023. PMID: 37738440 Free PMC article.

6

Clinical evaluation of a multitarget fecal immunochemical test-sDNA test for colorectal cancer screening in a high-risk population: a prospective, multicenter clinical study.

Hu YT, Chen XF, Zhai CB, Yu XT, Liu G, Xiong ZG, Wang ZQ, Cai SJ, Li WC, Kong XX, Xiao Q, Wang CH, Tao ZH, Niu LY, Men JL, Wang Q, Wei SZ, Hu JJ, Yang TH, Peng JJ, Jiang GZ, Lv N, Chen YY, Zheng S, Gu YH, Ding KF. Hu YT, et al. MedComm (2020). 2023 Aug 12;4(4):e345. doi: 10.1002/mco2.345. eCollection 2023 Aug. MedComm (2020). 2023. PMID: 37576863 Free PMC article.

7

Patient-derived organoids as a platform for drug screening in metastatic colorectal cancer.

He X, Jiang Y, Zhang L, Li Y, Hu X, Hua G, Cai S, Mo S, Peng J. He X, et al. Among authors: cai s. Front Bioeng Biotechnol. 2023 May 22;11:1190637. doi: 10.3389/fbioe.2023.1190637. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37284236 Free PMC article.

8

Molecular Profiling Provides Clinical Insights Into Targeted and Immunotherapies as Well as Colorectal Cancer Prognosis.

Guo L, Wang Y, Yang W, Wang C, Guo T, Yang J, Shao Z, Cai G, Cai S, Zhang L, Hu X, Xu Y. Guo L, et al. Among authors: cai s. Gastroenterology. 2023 Aug;165(2):414-428.e7. doi: 10.1053/j.gastro.2023.04.029. Epub 2023 May 3. Gastroenterology. 2023. PMID: 37146911 Free article.

9

Early Detection of Molecular Residual Disease and Risk Stratification for Stage I to III Colorectal Cancer via Circulating Tumor DNA Methylation.

Mo S, Ye L, Wang D, Han L, Zhou S, Wang H, Dai W, Wang Y, Luo W, Wang R, Xu Y, Cai S, Liu R, Wang Z, Cai G. Mo S, et al. Among authors: cai s. JAMA Oncol. 2023 Jun 1;9(6):770-778. doi: 10.1001/jamaoncol.2023.0425. JAMA Oncol. 2023. PMID: 37079312 Free PMC article.

10

Newly developed 3D in vitro models to study tumor-immune interaction.

Mu P, Zhou S, Lv T, Xia F, Shen L, Wan J, Wang Y, Zhang H, Cai S, Peng J, Hua G, Zhang Z. Mu P, et al. Among authors: cai s. J Exp Clin Cancer Res. 2023 Apr 4;42(1):81. doi: 10.1186/s13046-023-02653-w. J Exp Clin Cancer Res. 2023. PMID: 37016422 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

302 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

302 results

Results by year